AstraZeneca PLC (LON:AZN)
13,802p+0.48%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Exceptional cancer drug franchise delivering approvals at historic pace; the premium valuation is increasingly justified.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Cr…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - General
- Market Cap:
- £217.2B
Recent dividends
- 19 Feb 2026160p
- 7 Aug 202576.70p
- 20 Feb 2025168p
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on AstraZeneca PLC and 1,600+ UK and US stocks.
Start free